MicroRNA-7641 is a regulator of ribosomal proteins and a promising targeting factor to improve the efficacy of cancer therapy
Abstract Many diseases, including myocardial infarction, autoimmune disease, viral diseases, neurodegenerative diseases, and cancers, are frequently diagnosed with aberrant expression of microRNAs (miRNAs) and their allied pathways. This indicates the crucial role of miRNAs in maintaining biological...
Guardado en:
Autores principales: | Abu Musa Md. Talimur Reza, Yun-Jung Choi, Yu-Guo Yuan, Joydeep Das, Hideyo Yasuda, Jin-Hoi Kim |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/b426574a517c47118055a0d5e8063c4a |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Serum microRNAs are promising novel biomarkers.
por: Shlomit Gilad, et al.
Publicado: (2008) -
The promise of microRNA-based therapies in Alzheimer’s disease: challenges and perspectives
por: Hannah Walgrave, et al.
Publicado: (2021) -
microRNAs in human brucellosis: A promising therapeutic approach and biomarker for diagnosis and treatment
por: Sima Kazemi, et al.
Publicado: (2021) -
MicroRNA controlled adenovirus mediates anti-cancer efficacy without affecting endogenous microRNA activity.
por: Ryan Cawood, et al.
Publicado: (2011) -
Synergistic Internal Ribosome Entry Site/MicroRNA-Based Approach for Flavivirus Attenuation and Live Vaccine Development
por: Konstantin A. Tsetsarkin, et al.
Publicado: (2017)